Sign Up Today and Learn More About Ena Respiratory Stock
Invest in or calculate the value of your shares in Ena Respiratory or other pre-IPO companies through EquityZen's platform.
Ena Respiratory Stock
Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.
About Ena Respiratory Stock
Founded
2014
Industries
Software, Artificial Intelligence, Data and Analytics
Ena Respiratory Press Mentions
Stay in the know about the latest news on Ena Respiratory
Clinical trial launched to test experimental intranasal spray against respiratory viruses
news-medical • Feb 03, 2026
ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
pharmatimes • Jan 31, 2026
Announces Dosing of First Participants in Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections
pharmiweb • Jan 30, 2026
ENA Respiratory Announces Dosing of First Participants in Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections
pharmiweb • Jan 30, 2026
ENA Respiratory Announces Dosing of First Participants in Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections
biospace • Jan 30, 2026
Ena Respiratory Management
Leadership team at Ena Respiratory
Co-founder and CEO & Director
Christophe Demaison
Board Member
Christopher Smith
Join now and verify your accreditation status to gain access to:
- Ena Respiratory Current Valuation
- Ena Respiratory Stock Price
- Ena Respiratory Management
- Available deals in Ena Respiratory and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Ena Respiratory Cap Table and Funding History by Share Class and Liquidity Preferences
- Ena Respiratory Revenue and Financials
- Ena Respiratory Highlights
- Ena Respiratory Business Model
- Ena Respiratory Risk Factors
- Ena Respiratory Research Report from SACRA Research
Trading Ena Respiratory Stock
How to invest in Ena Respiratory stock?
Accredited investors can buy pre-IPO stock in companies like Ena Respiratory through EquityZen funds. These investments are made available by existing Ena Respiratory shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Ena Respiratory stock?
Shareholders can sell their Ena Respiratory stock through EquityZen's private company marketplace. EquityZen's network includes over 420K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."